Cargando…
Ferroptosis and WDFY4 as novel targets for immunotherapy of lung adenocarcinoma
Background: Lung cancer exhibits the world’s highest mortality rate among malignant cancers worldwide, thereby presenting a significant global challenge in terms of reducing patient mortality. In the field of oncology, targeted immunotherapy has emerged as a novel therapeutic approach for lung cance...
Autores principales: | Huang, Ling, Zhong, Lifan, Cheng, Ruxin, Chang, Limei, Qin, Mingyan, Liang, Huaping, Liao, Zhongkai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564425/ https://www.ncbi.nlm.nih.gov/pubmed/37728413 http://dx.doi.org/10.18632/aging.205042 |
Ejemplares similares
-
E26 Transformation-Specific-1 (ETS1) and WDFY Family Member 4 (WDFY4) Polymorphisms in Chinese Patients with Rheumatoid Arthritis
por: Zhang, Yiqun, et al.
Publicado: (2014) -
Regulation of Ferroptosis in Lung Adenocarcinoma
por: Wei, Xiangyun, et al.
Publicado: (2023) -
NRP2 transcriptionally regulates its downstream effector WDFY1
por: Dutta, Samikshan, et al.
Publicado: (2016) -
WDFY3 mutation alters laminar position and morphology of cortical neurons
por: Schaaf, Zachary A., et al.
Publicado: (2022) -
WDFY4 deficiency in NOD mice ameliorates autoimmune diabetes and insulitis
por: Ferris, Stephen T., et al.
Publicado: (2023)